Klaus Schafer - Sep 26, 2024 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Director
Signature
/s/ Andrew Shutterly, as Attorney-in-Fact
Stock symbol
ALT
Transactions as of
Sep 26, 2024
Transactions value $
$0
Form type
4
Date filed
9/30/2024, 06:34 PM
Previous filing
Sep 29, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALT Stock Options (option to buy) Award $0 +34.9K $0.00 34.9K Sep 26, 2024 Common Stock, par value $0.0001 34.9K $6.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 26, 2024, subject to the reporting person's continued service through the applicable vesting date.

Remarks:

Exhibit 24 - Power of Attorney